Explained herein are pharmaceutical packaging methods which reduce oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate drugs, these programs which includes a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite low permeability to oxygen and comprises